Regencell Bioscience Holdings Ltd (RGC)
4.64
+0.93
(+25.07%)
USD |
NASDAQ |
Apr 17, 16:00
4.64
0.00 (0.00%)
After-Hours: 16:37
Regencell Bioscience Holdings Total Liabilities (Quarterly): 0.6323M for June 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | 0.6323M |
December 31, 2022 | 0.8738M |
December 31, 2022 | 0.8738M |
June 30, 2022 | 0.938M |
December 31, 2021 | 1.364M |
Date | Value |
---|---|
December 31, 2021 | 1.364M |
June 30, 2021 | 4.338M |
December 31, 2020 | 3.585M |
December 31, 2020 | 3.585M |
June 30, 2020 | 3.165M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.6323M
Minimum
Jun 2023
4.338M
Maximum
Jun 2021
2.072M
Average
1.364M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
Global Pharmatech Inc | -- |
NovaBay Pharmaceuticals Inc | 5.72M |
Palatin Technologies Inc | 24.94M |
iBio Inc | 24.82M |
Theriva Biologics Inc | 15.52M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 12.62M |
Shareholders Equity (Quarterly) | 12.03M |